New pill shows promise against RSV in early trial
Disease control
Completed
This study tested an experimental oral drug called EDP-323 in 142 healthy adults who were deliberately infected with RSV. The goal was to see if the drug is safe and can reduce the amount of virus in the body compared to a placebo. The trial is complete, and results will help det…
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated May 01, 2026 21:58 UTC